Business
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand
Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen Announces Completion of Product Training with Sol Millennium as European Markets ExpandToronto, Ontario--(Newsfile Corp. - January 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the \"Company\" or \"NuGen\") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of January 30th, 2024, Sol-Millennium Medical Inc.'s (\"Sol-M\") global sales & marketing team has now completed their in-depth clinical training of NuGen's needle-free InsuJet™ medical device for sales and marketing throughout Europe. Louise Cresswell, NuGen's VP of Sales & Marketing for the UK and clinical expert, provided specialized training to a group of seven Sol-M sales representatives and equipped them with the necessary tools to employ a detail-oriented and proficient sales strategy for the European markets.Training specifically included detailed instructions and hands-on training of NuGen's InsuJet™ needle-free device to facilitate sales as it pertains to the diabetic markets in France and Spain.\"Well-attended sessions with very good interactions from Sol-M sales representatives enabled me to share our experiences, and clinician and patient feedback of the InsuJetTM system to help the Sol-M team to drive sales and product adoption in their target markets throughout Europe,\" commented Louise Cresswell, NuGen's VP of Sales & Marketing. \"The engagement and outcome with Sol-M were overwhelmingly positive with fulfillment set to achieve and perhaps even exceed expectations. I am very, very pleased,\" said Creswell.As planned, European order forecasts are to be received by NuGen from Sol-M in the coming weeks which is in keeping with expectations with first orders arriving before the end of Q1 2024.\"In January this year, I personally met overseas with Liang Lin, CEO of Sol-M, and am pleased to report a very positive relationship that will continue to grow further. After in-depth sales, marketing, and promotion training with Sol-M, which took months to complete, we are delighted to now go to market with our co-branded InsuJet™ needle-free medical device and consumables,\" commented Ian Heynen, CEO. \"As I stated earlier, 2024 will be a very busy year reporting commercial progress and wins in all three of our business verticals.\"About Sol-MSol-M, NuGen's dist...